-
Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc., et al. DC CAFC
- 1:14-cv-01268
- D. Del.
- Judge: Richard G. Andrews
+1
- Filed: 10/03/2014
- Closed: 12/12/2018
- Latest Docket Entry: 03/01/2019
- PACER
- Docket updated daily
1
Plaintiff
3
Defendants
2
Accused
Products
8
Patents-in-Suit
1,532
Days in
Litigation
-
Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc., et al. DC CAFC
- 1:14-cv-01268
- D. Del.
- Judge: Richard G. Andrews
+1
- Filed: 10/03/2014
- Closed: 12/12/2018
- Latest Docket Entry: 03/01/2019
- PACER
- Docket updated daily
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Hikma Americas Incorporated
- 5 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 7,964,647 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 7,964,648 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 7,981,938 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 8,097,655 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 8,440,722 B2 | All Asserted Claims |
No infringement
Entry 416
|
Hikma Pharmaceuticals PLC
- 5 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 7,964,647 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 7,964,648 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 7,981,938 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 8,097,655 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 8,440,722 B2 | All Asserted Claims |
No infringement
Entry 416
|
Hikma Pharmaceuticals USA, Inc.
- 5 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 7,964,647 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 7,964,648 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 7,981,938 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 8,097,655 B2 | All Asserted Claims |
No infringement
Entry 416
|
| Generic version of MITIGARE (colchicine) 0.6 mg capsules | US 8,440,722 B2 | All Asserted Claims |
No infringement
Entry 416
|
